Enantiomeric purity of synthetic therapeutic peptides: A review
Chirality · 2024-03 · 36 (3)
DOI: 10.1002/chir.23652 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chirality, online erschienen am 06.03.2024. Verfasst von Devendra Badgujar und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Pharmaceutical Education and Research-Ahmedabad, Ministry of Chemicals and Fertilizers, Government of India, Gandhinagar, Gujar…. Hauptthemen laut MEDLINE: Peptides. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 111 Literaturangaben.
Abstract (Originalsprache)
Synthetic therapeutic peptides are a complex and popular class of pharmaceuticals. In recent years, peptides with proven therapeutic activity have gained significant interest in the market. The determination of synthetic peptide enantiomeric purity plays a critical role in the evaluation of the quality of the medicine. Since racemization is one of the most common side reactions occurring in AAs or peptides, enantiomeric impurities such as D‐isomers can form during the peptide synthesis or can be introduced from the starting materials (e.g., AAs). The therapeutic effect of a synthetic or semi‐synthetic bioactive peptide molecule depends on its AA enantiomeric purity and secondary/tertiary structure. Therefore, the enantiomeric purity determination for synthetic peptides is supportive for interpreting unwanted therapeutic effects and determining the quality of synthetic peptide therapeutics. However, enantiomeric purity analysis encounters formidable analytical challenges during chromatographic separation, as D/L isomers have identical physical–chemical properties except stereochemical configuration. To ensure peptides AA stereochemical configuration whether in the free or bound state, sensitive and reproducible quantitative analytical method is mandatory. In this regard, numerous analytical techniques were emerged for the quantification of D‐isomeric impurities in synthetic peptides, but still, very few reports are available in the literature. Thus, the purpose of this paper is to provide an overview of the importance, regulatory requirements, and various analytical methods used for peptide enantiomeric purity determination. In addition, we discussed the available literature in terms of enantiomeric impurity detection, common hydrolysis procedural aspects, and different analytical strategies used for sample preparation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Pharmaceutical Education and Research-Ahmedabad, Ministry of Chemicals and Fertilizers, Government of India, Gandhinagar, Gujarat, India.
ORCID-Profile: Nitish Sharma
Zitieren
APA
Badgujar, D., Paritala, S. T., Matre, S., & Sharma, N. (2024). Enantiomeric purity of synthetic therapeutic peptides: A review. Chirality, 36(3). https://doi.org/10.1002/chir.23652
Vancouver
Badgujar D, Paritala ST, Matre S, Sharma N. Enantiomeric purity of synthetic therapeutic peptides: A review. Chirality. 2024;36(3). doi:10.1002/chir.23652
BibTeX
@article{Badgujar2024,
author = {Badgujar, Devendra and Paritala, Sree Teja and Matre, Shubham and Sharma, Nitish},
title = {Enantiomeric purity of synthetic therapeutic peptides: A review},
journal = {Chirality},
year = {2024},
volume = {36},
number = {3},
doi = {10.1002/chir.23652}
}
EUVIMED